Format

Send to

Choose Destination
J Intensive Care Med. 2019 Jul 17:885066619864541. doi: 10.1177/0885066619864541. [Epub ahead of print]

Ascorbic Acid, Thiamine, and Steroids in Septic Shock: Propensity Matched Analysis.

Author information

1
1 Mercy Hospital St Louis/St. Louis University, St. Louis, MO, USA.

Abstract

INTRODUCTION:

We aimed to study the use of ascorbic acid, thiamine, and steroids (ATS) in patients with septic shock (SS).

METHODS:

Data on 62 patients with SS were collected from Acute Physiologic and Chronic Health Evaluation (APACHE) Outcome database and medical records. The ATS group received full doses of intravenous (IV) ATS (ascorbic acid [1.5 g every 6 hours for 4 days], hydrocortisone [50 mg every 6 hours for 7 days], and thiamine [200 mg every 12 hours for 4 days]). Data included age, gender, APACHE III, acute physiologic score (APS), mechanical ventilation (MV), lactic acid (LA), serum creatinine (Cr), duration of vasopressors (VP, days, median: interquartile ranges [IQR]: [Q1, Q3]), MV-free days (median: IQR [Q1-Q3]), percentage of patients requiring renal replacement therapy (RRT) for acute kidney injury (AKI), and mortality. Propensity analysis was used to match patients on age, gender, MV, APACHE III, APS, LA, and Cr.

RESULTS:

The ATS group had longer duration of VP (4.5: 4.0-6.0 vs 2.0: 1.0-2.0, P = .001), similar RRT for AKI (26% vs 29%, P = .8), similar MV-free days (10.2: 5.0-15.0 vs 10.2: 1.6-18.0, P > .9), lower intensive care unit mortality (9.6% vs 42%, P = .004), and a trend toward lower hospital mortality (29% vs 45%, P = .2) compared to the NO ATS group.

CONCLUSIONS:

The use of IV ascorbic acid, thiamine, and hydrocortisone might be beneficial in patients with SS.

KEYWORDS:

ascorbic acid; mortality; outcome; sepsis; septic shock; steroids; thiamine; vitamin C

PMID:
31315499
DOI:
10.1177/0885066619864541

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center